Aimei Health Technology Co. Ltd. Secures $150,000 Extension Financing Through Promissory Note with Aimei Health Ltd. and United Hydrogen Group Inc

Reuters
Jul 08
<a href="https://laohu8.com/S/AFJK">Aimei Health</a> Technology Co. Ltd. Secures $150,000 Extension Financing Through Promissory Note with <a href="https://laohu8.com/S/AFJKU">Aimei Health</a> Ltd. and United Hydrogen Group Inc

Aimei Health Technology Co. Ltd. has announced the extension of its financial arrangement, enabling the company to further its business combination efforts. On July 6, 2025, Aimei Health Technology deposited an aggregate of $150,000 into its trust account, facilitating a one-month extension of its initial business combination period from July 6, 2025, to August 6, 2025. This extension is part of up to 12 extensions allowed under the company's Amended and Restated Articles of Association. Concurrently, Aimei Health issued an unsecured promissory note totaling $150,000 to its sponsor, Aimei Health Ltd., and United Hydrogen Group Inc., with each contributing $75,000. This note, which does not bear interest, is set to mature upon the company's consummation of a business combination with United Hydrogen. The involved parties retain the option to convert this note into private units of Aimei Health, consisting of ordinary shares and rights to additional shares, prior to the business combination's closing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-017980), on July 07, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10